Valencia, Spain

Andrés Gagete Mateos

USPTO Granted Patents = 6 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
6 patents (USPTO):

Title: The Innovative Contributions of Andrés Gagete Mateos

Introduction

Andrés Gagete Mateos is a prominent inventor based in Valencia, Spain. He has made significant contributions to the field of biopharmaceuticals, particularly through his innovative research and development of compounds that target specific interactions within the immune system. With a total of 6 patents to his name, Gagete Mateos is recognized for his impactful work in advancing medical treatments.

Latest Patents

Among his latest patents, Gagete Mateos has developed chromene derivatives that serve as inhibitors of the TCR-Nck interaction. This invention provides compounds that modulate the interaction of TCR with Nck, along with compositions and methods of treatment utilizing these compounds. His work in this area is crucial for developing new therapeutic strategies.

Career Highlights

Gagete Mateos has established himself as a key figure in the biopharmaceutical industry. He is currently associated with Artax Biopharma Inc., where he continues to push the boundaries of innovation in drug development. His expertise and dedication have led to advancements that could potentially transform treatment options for various diseases.

Collaborations

Throughout his career, Gagete Mateos has collaborated with notable professionals in the field, including Julio Castro and Peter J Machin. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Andrés Gagete Mateos exemplifies the spirit of innovation in the biopharmaceutical sector. His contributions through patents and collaborations highlight his commitment to advancing medical science. His work continues to inspire future developments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…